Imatinib Mesylate
In Stock•Starting at $6 for 100 mg•Purity ≥ 99%
| CAS No. | 220127-57-1 |
|---|---|
| MDL No. | MFCD04307699 |
| MF | C30H35N7O4S |
| MW | 589.70 |
| InChI Key | YLMAHDNUQAMNNX-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 100 mg | 99% | $6 | In Stock | |
| 250 mg | 99% | $6 | In Stock | |
| 1 g | 99% | $8 | In Stock | |
| 5 g | 99% | $18 | In Stock | |
| 25 g | 99% | $39 | In Stock |
Product Information
Imatinib methanesulfonate is the monomesylate salt of imatinib, used in the treatment of chronic myelogenous leukemia and gastrointestinal stromal tumors. It functions as an antineoplastic agent, apoptosis inducer, tyrosine kinase inhibitor, and anticoronaviral agent, and contains imatinib.
| CAS No. | 220127-57-1 |
|---|---|
| Product Name | Imatinib Mesylate |
| Heavy Atom Count | 42 | Rotatable Bond Count | 7 |
| Atom Stereo Count | 0 | Bond Stereo Count | 0 |
| HBA | 9 | HBD | 3 |
| TPSA | 140.650 Ų | Charge | 0 |
| Exact Mass | 589.24712 | Complexity | 1584.00 |
| pKa | 4.650 | XLogP | 4.094 |
